バイオテクノロジーニュース
-
October 30 , 2023
Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
詳しく見る -
October 30 , 2023
Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate
詳しく見る -
October 12 , 2023
MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech on the development of a next-generation antibody-drug conjugate candidate (“ADC”), against Human Epidermal Growth Factor Receptor 3 (HER3)
詳しく見る -
August 31 , 2020
An ingestible device for treating stomach ailments
- An international team of researchers has created an ingestible device that affixes itself to the stomach wall and treats ailments by delivering electrical pulses. In their paper published in the journal Science Advances, the group describes problems with current devices used to treat certain stomach ailments and how they overcame them to develop a device tha
詳しく見る -
August 30 , 2020
Research shows stimulating tuft cell production reverses intestinal inflammation
- Researchers at Vanderbilt University have, for the first time, been able to trigger the specific immune system response required to reverse the course of small intestinal inflammation by inducing production of tuft cells, very rare epithelial cells that sense and respond to parasites.
詳しく見る